Arianna Rubin-Means, MPH, PhD

Assistant Professor, Global Health

Dr. Arianna Rubin-Means, MPH, PhD focuses on generating operational evidence needed to improve the delivery of routine primary healthcare programs in low and middle-income countries, both within health facilities and in communities. She is currently the implementation science lead for the DeWorm3 Project, a series of large hybrid cluster randomized trials in Benin, India, and Malawi. She designs and manages the DeWorm3 Project’s qualitative research studies, organizational readiness research, operational research process mapping studies, and economic evaluations. She also leads implementation science activities for a multi-country network of facility-based child mortality studies, which aim to improve care for acutely ill children living in countries with limited resources and prevent both in-hospital and post-discharge mortality. Dr. Means teaches the online Fundamentals of Implementation Science course, providing training to over 200 implementation scientists around the world, as well as the annual CFAR implementation science mini-course.

A trained epidemiologist and implementation scientist, Dr. Means’ area of expertise is integrating evaluation of implementation outcomes into clinically oriented research to ensure that findings translate into the evidence needed to inform policy and guidelines. Dr. Means is a Scientific Associate at the Natural History Museum in London and an Associate Editor for PLOS Neglected Tropical Diseases.

1. Coe, MM, Shawon, RA, Masheti, M, Oduol, C, Amam, P, Olieng'o, GO et al.. "Though there are some challenges, we try our best to follow the guidelines": a qualitative study exploring determinants of providing guideline-adherent care to hospitalized children in Kenya. Implement Sci Commun. 2025;6 (1):110. doi: 10.1186/s43058-025-00790-1. PubMed PMID:41146284 PubMed Central PMC12560299.
2. Mangale, DI, Chhun, N, Majaha, M, Martin, C, Onyango, A, Mugo, C et al.. Determinants of feasibility, acceptability and reach of mobile phone delivery of an Adolescent Transition Package (ATP) supporting the transition of youth living with HIV to adult HIV care in Kenya during the COVID-19 pandemic. BMC Health Serv Res. 2025;25 (1):1311. doi: 10.1186/s12913-025-13305-4. PubMed PMID:41053768 PubMed Central PMC12502399.
3. Ajjampur, SSR, Aruldas, K, Ásbjörnsdóttir, KH, Avokpaho, E, Bailey, R, Cottrell, G et al.. Feasibility of interrupting the transmission of soil-transmitted helminths: the DeWorm3 community cluster-randomised controlled trial in Benin, India, and Malawi. Lancet. 2025;406 (10502):475-488. doi: 10.1016/S0140-6736(25)00766-4. PubMed PMID:40752908 .
4. Khosropour, CM, Healy, E, Murphy, EM, Means, AR, Pasha, E, Howard, J et al.. "I honestly didn't know it was for women too…" acceptability and feasibility of integrating PrEP services into OB/GYN practices from the perspectives of practice staff and cisgender women in the community: a qualitative study. Front Health Serv. 2025;5 :1567688. doi: 10.3389/frhs.2025.1567688. PubMed PMID:40521174 PubMed Central PMC12162616.
5. Aruldas, K, Ramesh, RM, Prasad, S, Israel, GJ, Legge, H, Walson, JL et al.. School-based deworming programmes: Knowledge and perceptions regarding soil-transmitted helminth infections among schoolteachers in Tamil Nadu, India. PLOS Glob Public Health. 2025;5 (3):e0004319. doi: 10.1371/journal.pgph.0004319. PubMed PMID:40163421 PubMed Central PMC11957371.